University of Twente-founded cartilage repair injection developer Hy2Care is currently targeting orthopaedic knee applications in veterinary and human healthcare settings.

Based on Clemson University research, 3D cancer cell modelling spinout Kiyatec has increased its total financing to $14.9m with the help of clinical lab operator LabCorp and VC firm VentureSouth.

Scottish Investment Bank and Innovate UK were among those backing University of Strathclyde brain cancer diagnosis spinout ClinSpec Diagnostics.

Cambridge Enterprise and CIC featured in cancer therapy developer PolyProx Therapeutics’ seed round, which will coommercialise research from the university’s pharmacology department.

Founded on inventions from Centre for Quantum Technologies, Speqtral is now set to commercialise its first application for quantum communications satellites.

Dilafor, a portfolio company of Karolinska Development, has attracted investors led by its manufacturing partner Opocrin to take its overall funding to more than $8.3m.

ETH Zurich spinout RosieReality has attracted $2.2m in seed capital led by Redalpine, with a contribution from existing backer Akatsuki.

University-industry collaboration matchmaking portal In-Part has added $1.2m from investors including Northern Powerhouse Investment Fund to $516,000 of seed capital procured in 2016.

Set up to identify fake news and social media bot accounts, Astroscreen has attracted UCL Technology Fund for its first funding round.

Four businesses have collected $37,000 in equity funding each from a micro-VC fund established by University of Waterloo’s Velocity unit in support of the Velocity Fund Finals competition.